LIR Life Sciences Advances Needle-Free Delivery of Large Molecules
VANCOUVER, CANADA | January 22, 2026 — LIR Life Sciences has announced the completion of the study design for...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
VANCOUVER, CANADA | January 22, 2026 — LIR Life Sciences has announced the completion of the study design for...
Vancouver, BC, September 23, 2025 – InMed Pharmaceuticals has reported its full‐year fiscal 2025 financial results and provided a...
